Docking and Virtual Screening to Identify PKC Agonists: Potentials in Anticancer Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|10|1|50-58

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.10, Iss.1, 2014-03, pp. : 50-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Conotoxins: Review and Docking Studies to determine potentials of Conotoxin as an Anticancer Drug Molecule

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 8, 2012-04 ,pp. : 845-851

Bentham Science Publishers

Access to resources Recommend Favorite

Brain Slices as Models for Neurodegenerative Disease and Screening Platforms to Identify Novel Therapeutics

By  

Current Neuropharmacology, Vol. 5, Iss. 1, 2007-01 ,pp. : 19-33

Bentham Science Publishers

Access to resources Recommend Favorite

The Challenge of Considering Receptor Flexibility in Ligand Docking and Virtual Screening

By  

Current Computer - Aided Drug Design, Vol. 1, Iss. 4, 2005-10 ,pp. : 423-440

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand Docking and Structure-based Virtual Screening in Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-05 ,pp. : 1006-1014

Bentham Science Publishers

Access to resources Recommend Favorite

Virtual Screening of Drugs: Score Functions, Docking, and Drug Design

By  

Current Computer - Aided Drug Design, Vol. 4, Iss. 4, 2008-12 ,pp. : 265-272

Bentham Science Publishers

Access to resources Recommend Favorite